Epstein-Barr Virus Infection
NEJM 343:481-492, Cohen,J.I., 2000
A Case of Balamuthia mandrillaris Meningoencephalitis
Arch Neurol 57:1210-1212, Katz,J.D. et al, 2000
Incidence and Prevalence of Neurological Disorders Associated with HIV Since the Introduction of Highly Active Antiretroviral Therapy (HAART)
JNNP 69:376-380, Maschke,M. et al, 2000
Infection Related to Intracranial Pressure Monitors in Adults: Analysis of Risk Factors and Antibiotic Prophylaxis
JNNP 69:381-384, Rebuck,J.A. et al, 2000
Chorioamnionitis as a Risk Factor for Cerebral Palsy
JAMA 284:1417-1424, Wu,Y.W. & Colford,J.M., 2000
Early Diagnosis of Zoster Sine Herpete and Ativiral Therapy for the Treatment of Facial Palsy
Neurol 55:708-710, Furuta,Y. et al, 2000
Multiple Sclerosis
NEJM 343:938-952, Noseworthy,J.H. et al, 2000
Intramuscular Interferon Beta-1a Therapy Initiated During a First Demyelinating Event in Multiple Sclerosis
NEJM 343:898-904, Jacobs,L.D. et al, 2000
Acute Disseminated Encephalomyelitis After Parenteral Therapy with Herbal Extracts: A Report of Two Cases
JNNP 69:516-518, Schwarz,S.,et al, 2000
Remedies for HIV-associated Peripheral Neuropathy
Neurol 54:2037-2038, Berger,J.R. &Nath,A., 2000
Adverse Effects of Antiretroviral Therapy
Lancet 356:1423-1430, Carr,A. &Cooper, D.A., 2000
Salmonella Typhimurium Brain Abscess:Postoperative Complication
CID 30:521-622, Kumari,P. & Kan,V.L., 2000
Multiple Sclerosis, Side Effects of Interferon Beta Therapy and Their Management
Neurol 53:1622-1627, Walther,E.U.&Hohlfeld,R., 1999
Acute Disseminated Encephalomyelitis:MR Imaging Features
AJR 173:1101-1107, Singh,S.,et al, 1999
Treatment Recommendations for Interferon-B in Multiple Sclerosis
JNNP 67:561-566, Polman,C.H.,et al, 1999
Benign Acute Childhood Myositis, Laboratory and Clinical Features
Neurol 53:2127-2131, Mackay,M.T.,et al, 1999
Herpes Varicella Zoster Encephalitis in Immunocompromised Patients
Neurol 52:193-195, Weaver,S.,et al, 1999
Multiple Sclerosis,Therapeutic Update
Arch Neurol 56:277-280, Tselis,A.C.&Lisak,R.P., 1999
HAART Improves Prognosis in HIV-Associated Progressive Multifocal Leukoencephalopathy
Neurol 52:623-625,440, Clifford,D.B.,et al, 1999
Diagnosis of Viral Infections of the Central Nervous System
NEJM 340:483-484, Huang,C.,et al, 1999
Severe Anaphylaxis with Recombinant Interferon Beta
Neurol 52:425, Corona,T.,et al, 1999
Clinicopath Conf,Hepatitis C,Type II Cryoglobulinemia,Vasculitis,B-cell Lymphoma,Mononeuritis Multiplex,Case 3-1999
NEJM 340:300-307, , 1999
Diffusion-Weighted MR Imaging of Encephalitis
AJR 173:1097-1099, Tsuchiya,K.,et al, 1999
Outbreak of Nipah-Virus Infection Among Abattoir Workers in Singapore
Lancet 354:1253-1256,1222, Paton,N.I.,et al, 1999
Fatal Encephalitis Due to Nipah Virus Among Pig-Farmers in Malaysia
Lancet 354:1257-1259,1222, Chua,K.B.,et al, 1999
Exotic Diseases Close to Home
Lancet 354:1221,1261, Briese,T.,et al, 1999
Interferon-B-1a in Relapsing-Remitting Multiple Sclerosis:Effect on Hypointense Lesion Volume on T1 Weighted Images
JNNP 67:579-584, Gasperini,C.,et al, 1999
Population Based Cost Utility Study of Interferon Beta-1b in Secondary Progressive Multiple Sclerosis
BMJ 319:1529-1533, Forbes,R.B.,et al, 1999
Clinicopath Conf,Guillain-Barre Syndrome, Campylobacter Jejuni Enteritis,Case 39-1999
NEJM 341:1996-2003, , 1999
Bell's Palsy and HSV-1 Infection
Muscle & Nerve 22:1476-1478, Marra,C.M., 1999
Demyelinative Brainstem Encephalitis Responsive to Intravenous Immunoglobulin Therapy
Pediatrics 104:301-304, Assa,A.,et al, 1999
Magnetic Resonance Imaging Results of the PRISMS Trial:A Randomized, Double-Blind, Placebo-Controlled Study of Interferon-B1a in Relapsing-Remitting Multiple Scleroosis
Ann Neurol 46:197-206, Li,D.K.B.,et al, 1999
Intravenous Immunoglobulin Treatment in Neurologic Disorders
Arch Neurol 56:1025-1027,1032, Sorensen,P.S., 1999
Herpes Simplex Encephalitis After Brain Surgery:Case Report and Review of the Literature
JNNP 67:239-242, Spuler,A.,et al, 1999
St. Louis Encephalitis and the Substantia Nigra:MR Imaging Evaluation
AJNR 20:1281-1283, Cernak,F.,et al, 1999
Prognostic Factors of Guillain-Barre Syndrome After Intravenous Immunoglobulin or Plasma Exchange?
Neurol 53:598-604, Visser,L.H.,et al, 1999
Dancing Eyes-Dancing Feet
Lancet 354:390, Imtiaz,K.E.&Vora,J.P., 1999
Evidence of Interferon B-1a Dose Response In Relapsing-Remitting MS, The OWIMS Study
Neurol 53:679-686, The Once Weekly Interferon for MS Study Group (OWI, 1999
Highly Active Antiretroviral Therapy Reverses Brain Metabolite Abnormalities in Mild HIV Dementia
Neurol 53:782-789, Chang,L.,et al, 1999
Neurologic Complications Associated with Hepatitis C Virus Infection
Neurol 53:861-864, Tembl,J.I.,et al, 1999
Disease-Modifying Drugs for Relapsing-Remitting Multiple Sclerosis and Future Directions for Multiple Sclerosis Therapeutics
Arch Neurol 56:1079-1084, Rudick,R.A., 1999
Encephalitis after Hepatitis B Vaccination, Recurrent Disseminated Encephalitis or MS?
Neurol 53:396-401, Tourbah,A.,et al, 1999
Risk of Transmission of Bovine Spongiform Encephalopathy to Humans in the United States, Report of the Council on Scientific Affairs
JAMA 281:2330-2339, Tan,L.,et al, 1999
Variant Creutzfeldt-Jakob Disease
Lancet 354:317-323, Collinge,J., 1999
Glucocorticoids in Central Nervous System Bacterial Infection
Arch Neurol 56:796-801, Coyle,P.K., 1999
Chlamydia Pneumoniae Infection of the Central Nervous System in Multiple Sclerosis
Ann Neurol 46:6-14,4, Sriram,S.,et al, 1999
Prevention of Postherpetic Neuralgia
Lancet 353:1636-1637, Dworkin,R.H., 1999
Reye's Syndrome in the United States from 1981 Through 1997
NEJM 340:1377-1382,1423, Belay,E.D.,et al, 1999
Ibuprofen Treatment Versus Gradual Introduction of Interferon B-1b in patients with MS
Neurol 52:1893-1895, Rice,G.P.A.,et al, 1999
Association of Cervical Artery Dissection with Recent Infection
Arch Neurol 56:851-856, Grau,A.J.,et al, 1999